leadf
logo-loader
viewTrutrace Technologies Inc.
(
CSE:TTTOTC:TTTSF
)

TruTrace Technologies launches 2.0 version of its StrainSecure cannabis-tracking technology

The new version adds a number of new features to the blockchain-enabled technology, such as expanded API capabilities and digital documentation systems

Trutrace Technologies Inc. -
Other improvements include a real-time collaboration module, a detailed inventory management system, and risk mitigation and recall prevention tools

TruTrace Technologies Inc has launched a new version of its proprietary cannabis-tracking platform StrainSecure.

The 2.0 version of the platform adds a number of new features to the blockchain-enabled technology, such as expanded API capabilities and digital documentation systems.

Most notably, the enhanced scan page gives brands a fully-customizable solution to showcase their product’s quality to consumers and market directly from a scan of their packaging.

READ: TruTrace Technologies to roll out cannabis validator with top cannabis cultivator Flora Growth

Other improvements include a real-time collaboration module, a detailed inventory management system, and risk mitigation and recall prevention tools.

"Over the first two years of our business, and after extensive work with leading organizations such as Shoppers Drug Mart (Loblaws), University Health Network, and Deloitte, we’ve gained a deep understanding of the new challenges facing this industry. The second version of StrainSecure will allow us to provide our clients with turnkey tools specifically designed to support the quality of their products and increasing engagement with their customers,” TruTrace CEO Robert Galarza told shareholders in a statement.

According to Vancouver-based TruTrace, most software systems utilized in the industry are fragmented or built only to manage internal operations, which leads to increased administrative costs, reduced revenue and more risks. StrainSecure 2.0 is designed to decrease administrative costs, increase revenue, scale business operations and highlight product quality, the company noted.

Riviera Beverages COO Tony Antillon said that implementing StrainSecure could reduce or prevent recalls, keeping a company from “crippling losses".

"The technology developed by TruTrace is revolutionary not only in its ability to showcase good management practices in action, but also the ability to mitigate significant recall risks in the consumer packaged goods space," Antillon told investors.

"The costs associated with a recall are extremely high as manufacturers must cover costs on a per-store and per-item basis with lack of transparency and traceability being a major contributing factor.”

TruTrace develops fully integrated software, secured on a blockchain infrastructure, that allows brands to store, manage, share, and immediately access quality assurance and testing details, COAs, as well as motion and movement intelligence on inventory.

Contact Angela at angela@proactiveinvestors.com

Follow her on Twitter @AHarmantas

Quick facts: Trutrace Technologies Inc.

Follow
CSE:TTT

Price: 0.06 CAD

Market Cap: $9.16 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

TruTrace Technologies signs LOI to provide blockchain-secured ecosystem for...

TruTrace Technologies (CSE: TTT- OTCQB: TTTSF) CEO Robert Galarza joined Steve Darling from Proactive to bring news the company has announced that it has signed a letter of intent with Georgia-based PharmaCentra to support a clinical trial ecosystem built on standardized protocols and testing of...

on 2/3/21

2 min read